Bill Ackman's Biggest Stock Holding is Getting Hammered - Business Insider -BoardProspects

Bill Ackman's Biggest Stock Holding is Getting Hammered

Business Insider Sep 28 2015 BoardNews

Activist investor Bill Ackman's biggest stock holding is getting demolished. Shares of Valeant Pharmaceuticals plummeted on Monday after Democrats on the House Oversight and Government Reform Committee sent a letter to the committee's chairman, Jason Chaffetz (R-UT), asking him to subpoena the pharmaceutical company for documents related to price increases of acquired drugs, Bloomberg ...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- It Looks Like Bill Ackman Just Got A Huge Ally In His Fight For Botox-Maker Allergan also written by Julia La Roche
- CEOs and Executives of Companies Filing for Bankruptcy Make Millions also categorized in BoardNews
- TaskRabbit CEO Steps Down, Making Silicon Valley’s Diversity Outlook Bleak also categorized in BoardNews
- Ford Fires CEO Mark Fields; Former Steelcase Chief Jim Hackett To Take Over also categorized in BoardNews
- GMI Ratings Update | Duke Energy Corporation also published in Business Insider
- Bill Ackman Prepares 'The Most Important Presentation' Of His Career On Herbalife (HLF) also written by Julia La Roche
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Herbalife's Biggest Individual Shareholder Is Getting Smoked also written by Julia La Roche
- Billionaire Investor Bill Ackman Trims Stake In Chipotle, But Is Still Betting Big On Burritos With 5% Stake also categorized in BoardNews
- Dan Loeb Takes A New Stake In Dow Chemical And It's Now Third Point's Largest Positon also written by Julia La Roche

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content
Quotes
1. We believe that the stock price does not reflect the quality of Valeant's franchises and future cash flows, and the business development, capital allocation and operating abilities of its management team.
Topics Mentioned
Authors
- Julia La Roche